Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Healthcare
Buys517
Sells4614
Buy $$728.04M
Sell $$14.05B
Ratio1:19.29
% Change vs. Prior
Ratio -98.2%Value -95.8%
Technology
Buys286
Sells6352
Buy $$2.48B
Sell $$8.15B
Ratio1:3.29
% Change vs. Prior
Ratio +807.3%Value +4.7%
Industrials
Buys318
Sells2404
Buy $$111.26M
Sell $$6.94B
Ratio1:62.38
% Change vs. Prior
Ratio -70.0%Value +44.6%
Utilities
Buys33
Sells196
Buy $$1.77M
Sell $$6.90B
Ratio1:3902.73
% Change vs. Prior
Ratio -99.9%Value +2891.3%
Energy
Buys176
Sells897
Buy $$46.49M
Sell $$5.50B
Ratio1:118.36
% Change vs. Prior
Ratio -89.7%Value +135.1%
Financial Services
Buys1776
Sells2592
Buy $$886.55M
Sell $$4.49B
Ratio1:5.07
% Change vs. Prior
Ratio +40.9%Value +1.6%
Consumer Cyclical
Buys250
Sells1889
Buy $$564.05M
Sell $$2.37B
Ratio1:4.21
% Change vs. Prior
Ratio +444.2%Value -53.3%
Consumer Defensive
Buys103
Sells500
Buy $$65.31M
Sell $$1.76B
Ratio1:27.01
% Change vs. Prior
Ratio +72.3%Value -77.4%
Communication Services
Buys178
Sells747
Buy $$59.08M
Sell $$965.09M
Ratio1:16.33
% Change vs. Prior
Ratio -49.8%Value -9.6%
Basic Materials
Buys115
Sells335
Buy $$178.88M
Sell $$804.32M
Ratio1:4.50
% Change vs. Prior
Ratio -31.9%Value +69.0%
Real Estate
Buys176
Sells507
Buy $$86.96M
Sell $$293.89M
Ratio1:3.38
% Change vs. Prior
Ratio +1028.9%Value -85.4%
By Industry
Medical - Instruments & Supplies
Buys48
Sells111
Buy $$18.63M
Sell $$7.66B
Ratio1:411.32
% Change vs. Prior
Ratio -98.9%Value +138.4%
Independent Power Producers
Buys0
Sells12
Buy $$0.00
Sell $$5.30B
RatioAll Sells
Oil & Gas Exploration & Production
Buys111
Sells265
Buy $$12.21M
Sell $$3.54B
Ratio1:289.58
Aerospace & Defense
Buys41
Sells611
Buy $$15.58M
Sell $$3.22B
Ratio1:206.63
% Change vs. Prior
Ratio -94.1%Value +135.1%
Hardware, Equipment & Parts
Buys24
Sells617
Buy $$2.01B
Sell $$626.99M
Ratio3.20:1
% Change vs. Prior
Ratio +189195.2%Value +70.8%
Semiconductors
Buys23
Sells1081
Buy $$10.68M
Sell $$2.61B
Ratio1:244.74
% Change vs. Prior
Ratio -30.8%Value +64.2%
Biotechnology
Buys293
Sells3008
Buy $$454.76M
Sell $$1.99B
Ratio1:4.39
% Change vs. Prior
Ratio -55.8%Value -37.4%
Engineering & Construction
Buys11
Sells147
Buy $$2.69M
Sell $$2.00B
Ratio1:744.87
Specialty Retail
Buys47
Sells474
Buy $$199.77M
Sell $$1.76B
Ratio1:8.80
Software - Infrastructure
Buys57
Sells1590
Buy $$40.79M
Sell $$1.82B
Ratio1:44.51
% Change vs. Prior
Ratio +258.6%Value -40.8%
Medical - Healthcare Information Services
Buys16
Sells200
Buy $$29.82M
Sell $$1.75B
Ratio1:58.84
Software - Application
Buys111
Sells1643
Buy $$348.88M
Sell $$1.31B
Ratio1:3.77
% Change vs. Prior
Ratio +131.9%Value -36.1%
Renewable Utilities
Buys5
Sells22
Buy $$104.80K
Sell $$1.38B
Ratio1:13209.99
Asset Management
Buys841
Sells227
Buy $$256.35M
Sell $$1.06B
Ratio1:4.13
% Change vs. Prior
Ratio +78.8%Value -8.8%
Banks - Regional
Buys504
Sells646
Buy $$27.49M
Sell $$905.05M
Ratio1:32.93
Transactions (21078)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%
ALKAMI TECHNOLOGY, INC. (ALKT)
Linebarger Douglas A. — Chief Legal Officer
Shares
5,518
Price
$16.90
Total Value
$93.25K
Shares Held After
216,233
% of Holdings
2.5%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
4,198
Price
$1.43
Total Value
$6.00K
Shares Held After
170,736
% of Holdings
2.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
2,461
Price
$1.43
Total Value
$3.52K
Shares Held After
174,934
% of Holdings
1.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
3,068
Price
$1.43
Total Value
$4.39K
Shares Held After
177,395
% of Holdings
1.7%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
756
Price
$1.43
Total Value
$1.08K
Shares Held After
180,463
% of Holdings
0.4%
Penumbra Inc (PEN)
Yuen Maggie — Chief Financial Officer
Shares
2,432
Price
$342.30
Total Value
$832.47K
Shares Held After
18,353
% of Holdings
11.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
421
Price
$326.81
Total Value
$137.59K
Shares Held After
26,053
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
277
Price
$325.63
Total Value
$90.20K
Shares Held After
26,474
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
97
Price
$324.65
Total Value
$31.49K
Shares Held After
26,751
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
50
Price
$323.62
Total Value
$16.18K
Shares Held After
26,848
% of Holdings
0.2%
Arista Networks, Inc. (ANET)
Giancarlo Charles H — Director
Shares
1,300
Price
$129.95
Total Value
$168.93K
Shares Held After
1,784
% of Holdings
42.2%
Arista Networks, Inc. (ANET)
Giancarlo Charles H — Director
Shares
3,600
Price
$128.87
Total Value
$463.94K
Shares Held After
3,084
% of Holdings
53.9%
Arista Networks, Inc. (ANET)
Giancarlo Charles H — Director
Shares
3,100
Price
$127.90
Total Value
$396.49K
Shares Held After
6,684
% of Holdings
31.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
578
Price
$70.46
Total Value
$40.73K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,322
Price
$69.80
Total Value
$1.07M
Shares Held After
768,358
% of Holdings
2.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,051
Price
$1.43
Total Value
$5.79K
Shares Held After
240,755
% of Holdings
1.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$69.20
Total Value
$283.71K
Shares Held After
783,680
% of Holdings
0.5%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
2,590
Price
$1.43
Total Value
$3.70K
Shares Held After
244,806
% of Holdings
1.0%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
4,433
Price
$1.43
Total Value
$6.34K
Shares Held After
247,396
% of Holdings
1.8%
Pulmonx Corp (LUNG)
Lehman David Aaron — GENERAL COUNSEL
Shares
1,163
Price
$1.43
Total Value
$1.66K
Shares Held After
251,829
% of Holdings
0.5%
Vanda Pharmaceuticals Inc. (VNDA)
Moran Kevin Patrick — SVP, CFO & Treasurer
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%
Vanda Pharmaceuticals Inc. (VNDA)
Williams Timothy — SVP & General Counsel
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%
ORMAT TECHNOLOGIES, INC. (ORA)
Woelfel Jessica — GC, CCO, and CS
Shares
869
Price
$104.59
Total Value
$90.89K
Shares Held After
5,792
% of Holdings
13.0%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%
Vanda Pharmaceuticals Inc. (VNDA)
Wijkstrom Joakim — SVP, Chief Marketing Officer
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%
Showing 6551–6600 of 21078 transactions (page 132 of 422)